Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AbSci (ABSI)
NASDAQ:ABSI
AbSci (ABSI) Stock Price & Analysis
210 Followers
ABSI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.11 - $6.72
Previous Close$4.77
Volume1.60M
Average Volume (3M)1.56M
Market Cap
$537.98M
Enterprise Value$481.58M
Total Cash (Recent Filing)$72.36M
Total Debt (Recent Filing)$15.96M
Price to Earnings (P/E)-4.0
Beta2.76
Next Earnings
May 14, 2024EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.20
Shares Outstanding112,784,576
10 Day Avg. Volume1,529,722
30 Day Avg. Volume1,562,442
Standard Deviation0.38
R-Squared0.11
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)4.21
Price to Sales (P/S)1591.66
Price to Cash Flow (P/CF)-9.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue84.22
Enterprise Value/Gross Profit84.22
Enterprise Value/Ebitda-6.07
Forecast
1Y Price Target
$8.75Price Target Upside94.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
AbSci News
Bulls Say, Bears Say
Bulls Say
Drug DevelopmentAbsci reported promising preclinical data from its first clinical candidate ABS-101, demonstrating best-in-class potential for the treatment of inflammatory bowel disease.
Financial HealthThe successful $86.4M equity raise extends the company's financial runway, illustrating investor confidence.
Strategic PartnershipsManagement guided adding at least four partnerships in 2024, including at least one multi-program partnership, demonstrating the management's confidence in attracting a steady stream of partnership opportunities.
Bears Say
EarningsAbsci reported technology development revenues below consensus estimates.
Financial PerformanceThe company experienced a greater net loss per share than the consensus estimated net loss.
RevenueABSI announced preliminary Q4 results with revenues falling short of market expectations.
---
Ownership Overview
38.98% Insiders
12.56% Mutual Funds
9.85% Other Institutional Investors
38.61% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ABSI FAQ
What was AbSci’s price range in the past 12 months?
AbSci lowest stock price was $1.11 and its highest was $6.72 in the past 12 months.
What is AbSci’s market cap?
Currently, no data Available
When is AbSci’s upcoming earnings report date?
AbSci’s upcoming earnings report date is May 14, 2024 which is in 20 days.
How were AbSci’s earnings last quarter?
AbSci released its earnings results on Mar 21, 2024. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.212 by -$0.038.
Is AbSci overvalued?
According to Wall Street analysts AbSci’s price is currently Undervalued.
Does AbSci pay dividends?
AbSci does not currently pay dividends.
What is AbSci’s EPS estimate?
AbSci’s EPS estimate is -$0.21.
How many shares outstanding does AbSci have?
AbSci has 112,784,580 shares outstanding.
What happened to AbSci’s price movement after its last earnings report?
AbSci reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.212. Following the earnings report the stock price went up 3.733%.
Which hedge fund is a major shareholder of AbSci?
Currently, no hedge funds are holding shares in ABSI
---
AbSci Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.75 (94.01% Upside)
$8.75 (94.01% Upside)
Blogger Sentiment
Bullish
ABSI Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $1000.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
166.48%
12-Months-Change
Fundamentals
Return on Equity
-49.08%
Trailing 12-Months
Asset Growth
-30.76%
Trailing 12-Months
Company Description
AbSci
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
---
ABSI Stock 12 Months Forecast
Average Price Target
$8.75
▲(94.01% Upside)
Technical Analysis
Protagonist Therapeutics
―
Crinetics Pharmaceuticals
―
RAPT Therapeutics
―
Sutro Biopharma
―
Best Analysts Covering ABSI
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+159.03%
reiterated a buy rating last month
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +159.03% per trade.
---